Multiplex PCR Assays Market Report 2026

Multiplex PCR Assays Market Overview

• Multiplex PCR Assays market size has reached to $1.7 billion in 2025 • Expected to grow to $3.17 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Surge In Diagnostic Testing Demand Drives Growth In Multiplex PCR Assays Market • Market Trend: Next-Gen qPCR Systems Boost Multiplex PCR Assays With Advanced Automation • North America was the largest region in 2025.

What Is Covered Under Multiplex PCR Assays Market?

Multiplex PCR assays refer to a type of polymerase chain reaction (PCR) technique that allows simultaneous amplification and detection of multiple DNA or RNA targets within a single reaction. This method enhances efficiency by enabling the analysis of several genetic markers or pathogens in one test, providing comprehensive and cost-effective results. The main types of multiplex PCR assays include planar assays and bead-based assays. A planar assay is a type of multiplex PCR assay that involves tests conducted on a flat surface or platform, such as microplates or slides, which use arrays of probes fixed to a surface to simultaneously detect multiple targets in a single sample, providing efficient and high-throughput analysis. The products and services include consumables, instruments, software, and services used in applications such as disease diagnosis, research and development, and others. The end users include biopharmaceutical companies, clinical research organizations, academic research institutes, diagnostic centers, and others.

What Is The Multiplex PCR Assays Market Growth Forecast?

The multiplex pcr assays market size is expected to see rapid growth in the next few years. It will grow to $3.17 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to growing focus on early disease detection, rising demand for comprehensive diagnostic solutions, expansion of personalized medicine approaches, increasing investments in molecular diagnostics, growing adoption of multiplex assays in routine testing. Major trends in the forecast period include rising adoption of multiplex testing for infectious diseases, increasing demand for high-throughput diagnostic assays, growing use of syndromic testing panels, expansion of multiplex pcr in clinical diagnostics, increasing preference for cost-effective multi-target assays.

Global Multiplex PCR Assays Market Segmentation

1) By Assay Type: Planar Assay, Bead Based Assay 2) By Product And Services: Consumables, Instruments, Software And Services 3) By Application: Disease Diagnosis, Research And Development, Other Applications 4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users Subsegments: 1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays 2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays

What Is The Driver Of The Multiplex PCR Assays Market?

The increasing demand for diagnostic testing is expected to propel the growth of the multiplex PCR assay market going forward. Diagnostic testing involves procedures or tests used to determine the presence or absence of a disease or condition in a patient. The rising demand for diagnostic testing is driven by increasing chronic diseases like cancer and diabetes, which require early and accurate diagnosis for effective management. Additionally, the focus on preventive healthcare encourages regular testing to detect potential issues early. Multiplex PCR assays allow for the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, enhancing the efficiency and comprehensiveness of diagnostic testing. For instance, in July 2024, according to the National Health Service (NHS), a U.K.-based hospital and healthcare provider, diagnostic activity exceeded pre-pandemic levels in 2023, with a 21% increase in tests performed in May 2024 compared to 2023 and 2.4 million diagnostic tests were carried out in May 2024. Therefore, the increasing demand for diagnostic testing will propel the growth of the multiplex PCR assay industry.

Key Players In The Global Multiplex PCR Assays Market

Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc, Agena Bioscience, Fluidigm Corporation

Global Multiplex PCR Assays Market Trends and Insights

Major companies operating in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to provide precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems offer high-throughput, accurate, and simultaneous detection of multiple targets, improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Switzerland-based diagnostic system solutions manufacturer, launched the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets. It features enhanced temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays, improving diagnostic accuracy and efficiency. This system exemplifies the integration of automation in the Multiplex PCR Assays market, advancing clinical diagnostics and public health.

What Are Latest Mergers And Acquisitions In The Multiplex PCR Assays Market?

In July 2023, QIAGEN N.V. a Germany-based biotechnology company partnered with Niba Labs.Niba Labs partnership aims to boost research in genomic testing and personalized medicine by offering advanced tools, data analysis, and expertise to drive innovation in biotech and healthcare. Niba Labs is a US-basedbiotechnology company that focuses on developing and manufacturing products for genomic research, molecular diagnostics, and personalized medicine.

Regional Outlook

North America was the largest region in the multiplex PCR assays market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Multiplex PCR Assays Market?

The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.